PMID: 9437624Jan 23, 1998Paper

Naltrexone pharmacotherapy for opioid dependent federal probationers

Journal of Substance Abuse Treatment
James W CornishC P O'Brien

Abstract

Federal probationers or parolees with a history of opioid addiction were referred by themselves or their probation/parole officer for a naltrexone treatment study. Participation was voluntary and subjects could drop out of the study at any time without adverse consequences. Following orientation and informed consent, 51 volunteers were randomly assigned in a 2:1 ratio to a 6-month program of probation plus naltrexone and brief drug counseling, or probation plus counseling alone. Naltrexone subjects received medication and counseling twice a week; controls received counseling at similar intervals. All therapy and medication were administered in an office located adjacent to the federal probation department. Fifty-two percent of subjects in the naltrexone group continued for 6 months and 33% remained in the control group. Opioid use was significantly lower in the naltrexone group. The overall mean percent of opioid positive urine tests among the naltrexone subjects was 8%, versus 30% for control subjects (p < .05). Fifty-six percent of the controls and 26% of the naltrexone group (p < .05) had their probation status revoked within the 6-month study period and returned to prison. Treatment with naltrexone and brief drug counseling...Continue Reading

References

Aug 1, 1978·The International Journal of the Addictions·D C LewisR Black
Jan 1, 1978·The American Journal of Drug and Alcohol Abuse·L S BrahenM J Lewis
Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·C P O'BrienG E Woody
Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·D C Lewis
Jan 1, 1974·The American Journal of Drug and Alcohol Abuse·A J SchecterD J Grossman
Jun 1, 1973·Archives of General Psychiatry·W R MartinP A Mansky
Jul 1, 1984·Drug and Alcohol Dependence·B A Judson, A Goldstein
Oct 1, 1983·Drug and Alcohol Dependence·R A GreensteinC P O'Brien
Jun 15, 1994·Biological Psychiatry·E N ShufmanY Ginath
Mar 1, 1994·The Journal of Nervous and Mental Disease·A I AltermanF X Schrade

❮ Previous
Next ❯

Citations

Jul 3, 2008·JAMA : the Journal of the American Medical Association·Charles P O'Brien
Feb 20, 2010·European Journal of Clinical Pharmacology·Philipp LobmaierJorgen Bramness
Oct 6, 2000·General Hospital Psychiatry·M A Adler Cohen, J M Jacobson
Apr 27, 1999·Drug and Alcohol Dependence·K L PrestonC R Schuster
Jun 11, 2003·Journal of Consulting and Clinical Psychology·William Fals-Stewart, Timothy J O'Farrell
Aug 11, 2004·Journal of Consulting and Clinical Psychology·Samuel A BallKathleen M Carroll
Jun 27, 2002·Addiction·Herbert D Kleber
Mar 29, 2001·The Australian and New Zealand Journal of Mental Health Nursing·R Brown, R Lo
Aug 13, 2003·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Colin Brewer, Emmannuel Streel
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Donna M CovielloCharles P O'Brien
Dec 4, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Silvana De Castro, Eduardo Sabaté
Jul 22, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Charles P O'Brien
May 19, 2007·Addiction Biology·Boukje A G DijkstraCees P F van der Staak
Jul 30, 1999·BMJ : British Medical Journal·J StrangM Gossop
Jun 17, 2008·Science & Practice Perspectives·Douglas B Marlowe
Dec 6, 2005·Journal of Health Care for the Poor and Underserved·Kim M BlankenshipKristin Mattocks
Feb 4, 2012·Future Medicinal Chemistry·Craig R Rush, William W Stoops
Jan 1, 2009·International Journal of Prisoner Health·M T ArendsG I C M Van 't Hoff
Nov 12, 2005·Substance Use & Misuse·Karen L CropseyChristina L St Clair
May 30, 2012·The Psychiatric Clinics of North America·Benjamin R Nordstrom, A R Williams
Jul 15, 2003·The American Journal on Addictions·Herbert D Kleber
May 19, 2012·Addiction·Colin Brewer
Aug 19, 2010·The American Journal on Addictions·Donna M CovielloCharles P O'Brien
Dec 22, 2004·Journal of Substance Abuse Treatment·Thamizan TuckerHenry Jackson
Jun 9, 2004·Journal of Substance Abuse Treatment·Evgeny M KrupitskyGeorge E Woody
Aug 22, 2006·Journal of Substance Abuse Treatment·Charles O'Brien, James W Cornish
Aug 22, 2006·Journal of Substance Abuse Treatment·Nicholas S Patapis, Benjamin R Nordstrom
Nov 7, 2006·Journal of Substance Abuse Treatment·Evgeny M KrupitskyGeorge E Woody
Dec 20, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hendrik G RoozenAd J F M Kerkhof
Sep 27, 2005·Pharmacology & Therapeutics·Charles P O'Brien, Eliot L Gardner
Aug 9, 2005·Pharmacology & Therapeutics·Frank Vocci, Walter Ling
Jun 28, 2005·Life Sciences·Luigi StellaFrancesco Ambrosino
Mar 6, 2010·Annals of the New York Academy of Sciences·David V HerinJohn Grabowski
May 8, 2010·Drug and Alcohol Review·Hans O Melberg, Keith Humphreys
Oct 24, 2012·British Journal of Clinical Pharmacology·Nikolaj KunøeGary Hulse
Aug 10, 2007·Expert Opinion on Investigational Drugs·Sandra D ComerGary K Hulse
Apr 8, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael S GordonHamin Shabazz
Mar 25, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lara A RayKaren Miotto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved